4.5 Article

Objective Measurement of Cough Frequency During COPD Exacerbation Convalescence

Journal

LUNG
Volume 194, Issue 1, Pages 117-120

Publisher

SPRINGER
DOI: 10.1007/s00408-015-9782-y

Keywords

COPD; Cough; Exacerbation; Outpatient monitoring; Telehealth

Funding

  1. Philips
  2. National Institute for Health Research [CL-2012-03-001] Funding Source: researchfish

Ask authors/readers for more resources

Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. Cough and sputum production are associated with adverse outcomes in COPD and are common during COPD exacerbation (AE-COPD). This study of objective cough monitoring using the Hull Automated Cough Counter and Leicester Cough Monitor software confirms that this system has the ability to detect a significant decrease in cough frequency during AE-COPD convalescence. The ability to detect clinically meaningful change indicates a potential role in home monitoring of COPD patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Public, Environmental & Occupational Health

Helping the quitters quit: A systematic review and narrative synthesis of the barriers and facilitators to e-cigarette cessation and the support that is needed

Judith Dyson, Malvika Bhatnagar, James Skinner, Michael Crooks

Summary: This study aims to investigate the barriers and facilitators to e-cigarette cessation and the support needed. Through systematic searches and paper selection, it was found that barriers to e-cigarette cessation include fear of returning to tobacco, dependency, and stress reduction. Additionally, health and hazard beliefs, degree of enjoyment, social influences, and environmental factors are identified as barriers or facilitators. Several support measures for e-cigarette cessation were suggested. Therefore, addressing these specific barriers to e-cigarette cessation should be considered in intervention design.

PATIENT EDUCATION AND COUNSELING (2022)

Article Medicine, General & Internal

Effect of Noninvasive Respiratory Strategies on Intubation or Mortality Among Patients With Acute Hypoxemic Respiratory Failure and COVID-19 The RECOVERY-RS Randomized Clinical Trial

Gavin D. Perkins, Chen Ji, Bronwen A. Connolly, Keith Couper, Ranjit Lall, J. Kenneth Baillie, Judy M. Bradley, Paul Dark, Chirag Dave, Anthony De Soyza, Anna Dennis, Anne Devrell, Sara Fairbairn, Hakim Ghani, Ellen A. Gorman, Christopher A. Green, Nicholas Hart, Siew Wan Hee, Zoe Kimbley, Shyam Madathil, Nicola McGowan, Benjamin Messer, Jay Naisbitt, Chloe Norman, Dhruv Parekh, Emma M. Parkin, Jaimin Patel, Scott E. Regan, Clare Ross, Anthony J. Rostron, Mohammad Saim, Anita K. Simonds, Emma Skilton, Nigel Stallard, Michael Steiner, Rama Vancheeswaran, Joyce Yeung, Daniel F. McAuley

Summary: Among patients with acute hypoxemic respiratory failure due to COVID-19, an initial strategy of CPAP significantly reduced the risk of tracheal intubation or mortality compared with conventional oxygen therapy, but there was no significant difference between an initial strategy of HFNO compared with conventional oxygen therapy. The study may have been underpowered for the comparison of HFNO vs conventional oxygen therapy, and early study termination and crossover among the groups should be considered when interpreting the findings.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Respiratory System

Towards codesign in respiratory care: development of an implementation-ready intervention to improve guideline-adherent adult asthma care across primary and secondary care settings (The SENTINEL Project)

Lucia Crowther, Mark Pearson, Helena Cummings, Michael George Crooks

Summary: This article describes an experience-based codesign process for developing an implementation-ready intervention to reduce the overuse of short-acting beta agonist (SABA) and optimize asthma treatment.

BMJ OPEN RESPIRATORY RESEARCH (2022)

Article Medicine, Research & Experimental

Environmental Sustainability in Respiratory Care: An Overview of the healthCARe-Based envirONmental Cost of Treatment (CARBON) Programme

Alex Wilkinson, Ekaterina Maslova, Christer Janson, Yang Xu, John Haughney, Jennifer K. Quint, Nigel Budgen, Andrew Menzies-Gow, John Bell, Michael G. Crooks

Summary: The CARBON program aims to assess the carbon footprint of respiratory care and identify strategies for reducing greenhouse gas emissions. It will quantify the carbon footprint of medications and healthcare resource utilization and explore the impact of different treatment approaches on greenhouse gas emissions in patients with respiratory diseases.

ADVANCES IN THERAPY (2022)

Editorial Material Critical Care Medicine

Chronic Cough in Idiopathic Pulmonary Fibrosis: The Same Difference?

Alyn H. Morice

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Pharmacology & Pharmacy

Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study

Christian Friedrich, Klaus Francke, Isabella Gashaw, Christian Scheerans, Stefan Klein, Lueder Fels, Jaclyn A. Smith, Thomas Hummel, Alyn Morice

Summary: This study investigated the safety and tolerability of repeated ascending oral doses of eliapixant in healthy volunteers. The results showed that eliapixant at doses of 200 mg and 750 mg achieved plasma concentrations that cover the predicted therapeutic threshold and demonstrated good safety and tolerability. These findings suggest that eliapixant has potential for use in clinical trials for refractory chronic cough.

CLINICAL PHARMACOKINETICS (2022)

Article Biochemistry & Molecular Biology

Nebivolol as a Potent TRPM8 Channel Blocker: A Drug-Screening Approach through Automated Patch Clamping and Ligand-Based Virtual Screening

Farhad Jahanfar, Laura Sadofsky, Alyn Morice, Massimo D'Amico

Summary: TRPM8 is an important ion channel involved in various diseases. This study identified two potential TRPM8 inhibitors through high-throughput screening, providing candidate drugs for further development.

MEMBRANES (2022)

Letter Critical Care Medicine

Efficacy and Safety of Gefapixant for Refractory or Unexplained Chronic Cough over 52 Weeks

Surinder S. Birring, Peter V. Dicpinigaitis, Jaclyn A. Smith, Alyn H. Morice, Lorcan P. McGarvey, Ian D. Pavord, Allison Martin Nguyen, Jonathan Schelfhout, Qing Li, Beata Iskold, Stuart A. Green, George Philip, David R. Muccino, Carmen La Rosa

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Letter Critical Care Medicine

What the Placebo Tells Us about Chronic Cough Reply

Surinder S. Birring, Alyn H. Morice, Peter V. Dicpinigaitis, Lorcan P. McGarvey, Ian D. Pavord, Stuart A. Green, George Philip, Jaclyn A. Smith

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2023)

Review Respiratory System

The vicious circle of chronic cough: the patient experience - qualitative synthesis

Kayleigh Brindle, Alyn Morice, Natalie Carter, Dominic Sykes, Mengru Zhang, Andrea Hilton

Summary: The aim of this study was to systematically search and synthesise findings from peer-reviewed qualitative studies describing the experiences of those living with chronic cough. The thematic synthesis generated three analytical themes: 1) It's just a cough; 2) Constant cough and constant worry; and 3) No light at the end of the tunnel, highlighting the biopsychosocial nature of chronic cough. The study emphasizes the need for more qualitative research on the experiences of those living with chronic cough.

ERJ OPEN RESEARCH (2023)

Article Respiratory System

Improving asthma care through implementation of the SENTINEL programme: findings from the pilot site

Michael G. Crooks, Lucia Crowther, Helena Cummings, Judith Cohen, Chao Huang, Lukas Pitel, Mark Pearson, Alyn Morice, John Turgoose, Shoaib Faruqi, Michael Watt, Tamsin Morris, Yang Xu

Summary: The SENTINEL programme aimed to reduce SABA overuse and promote MART as a preferred treatment for asthma. The implementation of the programme led to decreased SABA prescribing, increased uptake of inhaled corticosteroids, and fewer asthma exacerbations.

ERJ OPEN RESEARCH (2023)

Review Oncology

From bench to bedside: The role of cough hypersensitivity in chronic cough

Matthew G. Drake, Lorcan P. McGarvey, Alyn H. Morice

Summary: Chronic cough is a burdensome condition that significantly affects quality of life and lacks effective therapies. Recent studies have focused on targeting ion channels and receptors involved in cough activation and processing, providing new insights and treatment options for chronic cough.

CLINICAL AND TRANSLATIONAL MEDICINE (2023)

Article Respiratory System

Burden of chronic cough in the UK: results from the 2018 National Health and Wellness Survey

Lorcan McGarvey, Alyn H. Morice, Ashley Martin, Vicky W. Li, Michael J. Doane, Eduardo Urdaneta, Jonathan Schelfhout, Helen Ding, Eileen Fonseca

Summary: Chronic cough is highly prevalent in the UK and has a significant impact on quality of life, work productivity, and healthcare resource utilization.

ERJ OPEN RESEARCH (2023)

Letter Respiratory System

Chronic cough in cystic fibrosis: the effect of modulator therapy on objective 24-h cough monitoring

Mengru Zhang, Kayleigh Brindle, Melanie Robinson, Debbie Ingram, Tanya Cavany, Alyn Morice

ERJ OPEN RESEARCH (2022)

No Data Available